Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies
Closed Solicitation Posted
- Solicitation number
- 75F40126Q00204
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 112990 All Other Animal Production
- PSC
- 8820 Live Animals, Not Raised For Food
- Place of performance
- Silver Spring, Maryland 20993, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration's Center for Biologics Evaluation and Research seeks provision and delivery of twenty Bordetella-free baboons for pertussis infection and vaccination studies, with quotes due July 10, 2026, at 1:00 P.M. Central Time and questions due July 2. This is a firm fixed-price commercial item acquisition with no small-business set-aside.
Place of performance is the FDA White Oak Campus in Silver Spring, Maryland, Building 72 CBER Vivarium, with delivery required within ninety calendar days of contract award. Baboons must be six to eight months old, unvaccinated, and confirmed free of Bordetella exposure through blood draws and nasopharyngeal washes tested by CBER laboratories prior to shipment. All animals must be examined and certified in good health by a licensed veterinarian experienced in non-human primate medicine before shipment. The contractor must coordinate with USDA-licensed carriers and maintain liaison with carrier personnel to ensure proper care during transit in compliance with USDA standards and the CBER Institutional Animal Care and Use Committee protocol ASP#2009-19. An optional second line item allows return of animals upon conclusion of FDA studies at the same unit price. Quote validity must extend through September 30, 2026. The estimated award date is July 24, 2026, with the FDA study period running October 26, 2026, through December 25, 2027. Payment is Net-30 calendar days after government acceptance via the Invoice Processing Platform. The NAICS code is 112990, All Other Animal Production; PSC is 8820, Live Animals, Not Raised For Food. Evaluation prioritizes technical capability as most important, followed by past performance within three years, then price. Contact David Kramer, Contract Specialist, david.kramer@fda.hhs.gov, 703-447-2694.
Notice text
2 versions
Update #2 · Latest ·
6/29/2026; See attached amendment 1 to the combined synopsis/solicitation.
Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need.
The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients. Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.
Update #1 ·
Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need.
The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients. Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.
Files
| File | Type | Posted |
|---|---|---|
| Sol Doc 134085 Amendment 0001.pdf | ||
| Sol Doc 134085.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity